Evaluating the survival outcomes and analyzing prognostic factors of recurrent / metastatic pulmonary large cells neuroendocrine carcinoma patients treated with cisplatin plus etoposide chemotherapy at Vietnam National Cancer Hospital from 1/2018 to 10/2021.